Package 71610-730-30

{"route": ["ORAL"], "spl_id": "15eadc84-1f2f-7f49-e063-6394a90a9a77", "openfda": {"unii": ["WY6W63843K"], "rxcui": ["854880"], "spl_set_id": ["08411424-e8a8-4964-bd04-5b0b5aa5baaf"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-730-28)", "package_ndc": "71610-730-28", "marketing_start_date": "20240412"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-730-30)", "package_ndc": "71610-730-30", "marketing_start_date": "20230830"}], "brand_name": "ZOLPIDEM TARTRATE", "product_id": "71610-730_15eadc84-1f2f-7f49-e063-6394a90a9a77", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Depression [PE]", "GABA A Receptor Positive Modulators [MoA]", "gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]"], "product_ndc": "71610-730", "dea_schedule": "CIV", "generic_name": "Zolpidem Tartrate", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZOLPIDEM TARTRATE", "active_ingredients": [{"name": "ZOLPIDEM TARTRATE", "strength": "12.5 mg/1"}], "application_number": "ANDA078970", "marketing_category": "ANDA", "marketing_start_date": "20140411", "listing_expiration_date": "20261231"}